These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9410047)

  • 1. [Double-blind clinical trial comparing 5 days of dirithromycin versus 7 days of diacetylmidecamycin in acute bronchitis and acute exacerbations of chronic bronchitis].
    Sacristán JA; Elviro J; García de Lomas J; Palomino-Nicás J; Sobradillo V; Sánchez Gascón F; Valencia A; Calbo F; Viejo JL; Zamarrón C; Coca E; Casado MA; García Pérez LE; Hernández JM
    Enferm Infecc Microbiol Clin; 1997; 15(7):357-60. PubMed ID: 9410047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis.
    Gaillat J
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():139-51. PubMed ID: 8478305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of dirithromycin versus miocamycin in the treatment of acute bronchitis or acute exacerbations of chronic bronchitis.
    Pozzi E
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():153-8. PubMed ID: 8478306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis.
    Wasilewski MM; Johns D; Sides GD
    J Antimicrob Chemother; 1999 Apr; 43(4):541-8. PubMed ID: 10350384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis.
    Sides GD
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():131-8. PubMed ID: 8478304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
    Castaldo RS; Celli BR; Gomez F; LaVallee N; Souhrada J; Hanrahan JP
    Clin Ther; 2003 Feb; 25(2):542-57. PubMed ID: 12749513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Hosie J; Quinn P; Smits P; Sides G
    J Antimicrob Chemother; 1995 Jul; 36(1):173-83. PubMed ID: 8537264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dirithromycin versus amoxiclav in the treatment of acute exacerbations of chronic bronchitis.
    Van Royen P; Betz W; Heyrman J; Taziaux P; Van den Haute M; Poelman M
    J Int Med Res; 1997; 25(1):33-40. PubMed ID: 9027671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
    J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
    Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drugs--reports of new drugs recently approved by the FDA. Dirithromycin.
    Shinkai I; Ohta Y
    Bioorg Med Chem; 1996 Apr; 4(4):521-2. PubMed ID: 8735838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Busman TA; Norris S; Notario GF
    Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dirithromycin in the treatment of infections of the lower respiratory tract].
    Belousov IuB; Bykov AV; Komirova VP; Malikov VE; Minaev VI
    Antibiot Khimioter; 1995 Jul; 40(7):35-8. PubMed ID: 8645058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.
    Fogarty C; de Wet R; Mandell L; Chang J; Rangaraju M; Nusrat R
    Chest; 2005 Oct; 128(4):1980-8. PubMed ID: 16236845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
    Paster RZ; McAdoo MA; Keyserling CH; Nemeth MA; Tack KJ; Griffin TJ
    Int J Clin Pract; 2000 Jun; 54(5):293-9. PubMed ID: 10954955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
    Matthys H; de Mey C; Carls C; Ryś A; Geib A; Wittig T
    Arzneimittelforschung; 2000 Aug; 50(8):700-11. PubMed ID: 10994153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Notario G; Spiller J; Palmer R; Busman T
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Beeh KM; Beier J; Candler H; Wittig T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis.
    Zervos MJ; Heyder AM; Leroy B
    J Int Med Res; 2003; 31(3):157-69. PubMed ID: 12870368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.